Psychedelic retreats are a relatively new way for people to experiment with mushrooms, and the criticisms MycoMeditations has faced are indicative of the larger issues in the psychedelics industry.
Eight Capital's Ammar Shah is now the first analyst at an investment bank to cover the psychedelics industry. He estimates the market for mental-health treatments is as big as $100 billion.
People who took psychedelic drugs felt an "afterglow" hours later, and some even saw a shift in their moral values.
When you ingest psilocybin, your gut converts it into another chemical called psilocin, which triggers changes in the brain.
"Despite the small sample size, there is a strong, statistically significant suggestion that there are persisting effects of psilocybin-facilitated treatment well beyond the time course of acute drug action."